Supplementary Table 1.
Clinical Characteristics of the Patients
Patient / Age (years) / Sex / Presenting symptoms / Disease extent into the liver / Extrahepatic diseases / Positive tumor markers / Management / Follow-up (months) / Status at follow-up1 / 57 / M / Right upper abdominal pain/discomfort / Right lobar, mononodular / Absent / CA19-9 / LR / 2 / Dead
2 / 58 / M / Asymptomatic / Right lobar, multinodular / Absent / None / LR+TACE / 80 / Alive
3 / 65 / M / Right upper abdominal pain/discomfort / Right lobar, multinodular / Lung metastasis / CA19-9 / TACE / 3.5 / Dead
4 / 32 / F / Right upper abdominal pain/discomfort / Bilobar, multinodular / Absent / None / TACE / 3 / Lost follow-up
5 / 23 / M / Right upper abdominal pain/discomfort / Right lobar, multinodular / Absent / None / TACE / 5 / Lost follow-up
6 / 56 / M / Asymptomatic / Left lobar, mononodular / Absent / None / LR / 57 / Lost follow-up
7 / 43 / M / Asymptomatic / Right lobar, multinodular / Absent / None / TACE / 44 / Alive
8 / 63 / F / Right upper abdominal pain/discomfort / Bilobar, multinodular / Absent / None / LT / 12 / Dead
9 / 26 / F / Asymptomatic / Bilobar, multinodular / Absent / None / LR / 36 / Lost follow-up
10 / 60 / F / Jaundice / Right lobar, mononodular / Absent / CA19-9 / LR / 6 / Dead
11 / 47 / M / Asymptomatic / Right lobar, multinodular / Absent / None / LR / 25 / Lost follow-up
12 / 43 / M / Chest pain / Bilobar, multinodular / Lung metastasis / None / TACE / 1 / Dead
13 / 26 / F / Asymptomatic / Right lobar, multinodular / Diaphragm and abdominal wall metastasis / None / LR / 38 / Alive
14 / 62 / F / Weight loss / Bilobar, multinodular / Absent / None / LR / 7 / Dead
15 / 31 / F / Right upper abdominal pain/discomfort / Bilobar, multinodular / Absent / None / TACE / 34 / Alive
16 / 61 / M / Asymptomatic / Bilobar, multinodular / Absent / None / TACE / 12 / Lost follow-up
17 / 52 / M / Right upper abdominal pain/discomfort / Bilobar, multinodular / Absent / None / TACE / 0.25 / Dead
18 / 42 / M / Chest pain / Bilobar, multinodular / Lung metastasis / None / TACE / 27 / Alive
19 / 68 / M / Chest pain / Bilobar, multinodular / Absent / CA19-9 / TACE / 20 / Alive
20 / 58 / F / Asymptomatic / Right lobar, mononodular / Absent / CA19-9 / LR / 10 / Alive
21 / 37 / F / Asymptomatic / Bilobar, multinodular / Lung metastasis / None / TACE / 17 / Alive
22 / 22 / F / Asymptomatic / Left lobar, mononodular / Absent / None / LR / 22 / Alive
23 / 49 / M / Right upper abdominal pain/discomfort / Right lobar, mononodular / Absent / None / LR+TACE / 16 / Dead
24 / 38 / M / Right upper abdominal pain/discomfort / Right lobar, multinodular / Absent / None / LR / 52 / Alive
25 / 20 / M / Asymptomatic / Right lobar, mononodular / Absent / None / LR / 33 / Alive
26 / 23 / F / Right upper abdominal pain/discomfort / Right lobar, mononodular / Absent / None / LR / 30 / Alive
27 / 66 / F / Asymptomatic / Right lobar, multinodular / Absent / None / LR+TACE / 27 / Lost follow-up
28 / 80 / F / Right upper abdominal pain/discomfort / Right lobar, multinodular / Absent / None / LR / 20 / Alive
29 / 61 / F / Asymptomatic / Right lobar, mononodular / Absent / None / LR / 16 / Alive
30 / 33 / F / Asymptomatic / Right lobar, mononodular / Absent / None / LR / 15 / Alive
31 / 57 / F / Right upper abdominal pain/discomfort / Right lobar, mononodular / Diaphragm metastasis / None / LR / 14 / Alive
32 / 44 / F / Asymptomatic / Right lobar, multinodular / Absent / None / LR / 2 / Alive
33 / 35 / M / Asymptomatic / Bilobar, multinodular / Absent / None / TACE / 52 / Alive
F: female; M: male; LR: liver resections; LT: liver transplantation; TACE: transcatheter arterial chemoembolizations.